Generic vs Branded Medicines: Margins and Card-Fee Mechanics for Pharmacies

Generic vs Branded Medicines: Margins and Card-Fee Mechanics for Pharmacies

Published: 24 October 2026

Category: how-to-guides | cardbuzz

Tags: generic medicines, branded medicines, pharmacy margins, card fees, medical store, trade margins

Every pharmacy counter carries two broad kinds of medicine: branded products sold under a manufacturer's brand name, and generic products sold under the name of their active ingredient. Customers often ask which to choose, and pharmacies often think about the same question from the other side of the counter — what each kind means for margin, for stock, and for the cost of accepting a card payment. The economics differ in ways that are worth understanding, even though the card terminal treats both exactly the same.

This article explains the margin and card-fee mechanics of generic and branded medicines, without naming any specific product or price — the mechanics, not the catalogue, are the point.

What Generic and Branded Mean

The distinction is about naming and marketing, not about the medicine's purpose:

• Branded medicines are marketed under a brand name by a manufacturer, with the brand built through promotion, packaging and prescriber familiarity.
• Generic medicines are sold under the name of their active ingredient rather than a brand name, and are typically made by manufacturers other than the originator.
• Same active ingredient, different presentation. A generic and a branded product may share the same active ingredient and strength, while differing in manufacturer, packaging and price.
• Choice at the counter. In many cases the customer, sometimes with the prescriber's guidance, can choose between a branded and a generic option for the same requirement.

This article makes no recommendation about which a patient should take — that is a matter for the patient and their prescriber. The focus here is purely on how the two categories behave as pharmacy stock.

How Margins Differ

Margin is the difference between what the pharmacy pays for stock and what it sells it for, after trade terms. Generic and branded medicines tend to differ in margin structure:

• Branded products often carry established trade terms set by the manufacturer and distributor, with margins that are relatively stable but sometimes tight, because the brand's price is widely known and comparison is easy.
• Generic products often carry more variable trade terms, with margins that can be wider, because competition among generic manufacturers gives distributors and pharmacies more room to negotiate.
• Price visibility. A branded product's price is often well known to customers, which limits the pharmacy's pricing flexibility. A generic product's price is less widely known, which gives the pharmacy more room — but also more responsibility to price fairly.
• Volume patterns. Branded products may sell steadily because prescribers and patients know them. Generic products may sell in higher volumes where customers are price-conscious, but demand can shift between manufacturers.

The practical consequence is that a pharmacy's overall margin is a blend: the mix of generic and branded sales in a given month shapes the month's profitability more than any single product does.

Card Fees Cut Across Both Categories Equally

Here is the part that surprises many pharmacy owners: the card fee does not distinguish between generic and branded. MDR is calculated on the transaction value, whatever is in the basket. But the fee's impact differs because the margins differ:

• Same fee proportion, different margin cushion. A card fee deducted from a sale eats into the margin of that sale. Where the margin is thin, the fee takes a larger share of it; where the margin is wider, the fee is absorbed more comfortably.
• Basket mix matters. A bill made up mostly of thin-margin branded items leaves less room after card fees than a bill with a healthier generic mix — even when the two bills total the same amount.
• Illustrative comparison. Consider two illustrative ₹10,000 bills: one composed of thin-margin items and one of wider-margin items. The card fee deducted from each is the same in proportion, but the profit remaining after the fee differs noticeably. The fee is neutral; the margin is what varies.
• Discounts compound the effect. If a pharmacy offers a discount on top of a card-paid sale, the discount and the card fee both come out of the same margin. On thin-margin items, the combination can erase the profit on the sale entirely.

The lesson is not to steer customers by margin — customers must be free to choose — but to understand, at the level of the month's sales mix, how card fees interact with the margin profile of what was sold.

Stock, Expiry and Working Capital

Generic and branded stock behave differently as inventory, which affects the money tied up in the shop:

• Branded stock may turn over predictably, because demand is steady, but it can also tie up capital if the pharmacy over-stocks slow-moving brands.
• Generic stock may be cheaper per unit, so the same capital buys more units, but demand can shift between manufacturers, leaving slow-moving generic stock on the shelf.
• Expiry risk. Both categories carry expiry risk, and expired stock is a loss regardless of category. Stock rotation and expiry tracking matter for both.
• Card payments and cash flow. Card settlement timing affects cash flow for both categories equally — the store receives the sale value net of the card fee on the settlement schedule, regardless of what was sold. Managing that timing matters most when the store must pay distributors on a shorter cycle than its card settlements arrive.

A pharmacy that tracks margin by category, expiry by product, and settlement timing by payment mode has the three numbers it needs to manage working capital sensibly.

Pricing and Discount Decisions

Discounts are where generic-versus-branded economics meet the customer most visibly:

• Discounts come out of margin. Any discount a pharmacy offers reduces the margin on that sale, before the card fee is even considered.
• Discount capacity differs by category. Wider-margin generic sales can absorb a larger discount than thin-margin branded sales, for the same remaining profit.
• Blanket discounts are risky. A single discount percentage applied across the whole basket ignores the fact that the basket contains items with very different margins. A discount that is comfortable on one part of the basket may be loss-making on another.
• Transparency builds trust. Customers respond well to honest explanations of why a discount is available on some items and not others, particularly where prices are regulated or set by trade terms.

The discipline is to decide discounts with the margin profile in mind, not as a reflex to match a competitor's headline offer.

What This Means at the Counter

For counter staff, the generic-versus-branded distinction should be handled with care:

• Never steer by margin. A customer's choice between generic and branded should be guided by their prescriber and their own preference, never by which option is more profitable for the store.
• Answer price questions honestly. If a customer asks why two products with the same active ingredient cost different amounts, an honest explanation — branding, manufacturer, packaging, trade terms — serves the customer better than a vague answer.
• Keep the card conversation separate. Payment mode is a separate question from product choice. A customer paying by card should receive the same product advice as a customer paying cash.
• Record accurately. Bills should record exactly what was sold — generic or branded, manufacturer, quantity — so that margin analysis, stock records and any future query all rest on accurate data.

The Bottom Line for Pharmacies

Generic and branded medicines differ in margin structure, price visibility and stock behaviour, but the card fee treats them identically — it takes the same proportion of the bill either way. The pharmacy's job is to understand the blend: track margin by category, recognise that discounts and card fees both come out of the same margin, manage expiry and working capital for both categories, and never let margin considerations steer a customer's product choice. Understand the economics, keep product advice honest, and let the card fee be a known cost rather than a quiet surprise at month-end.